logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-8. Trends in last 12 months use of amphetamines among young adults (aged 15 to 34) [see all figures in this series...]

Part (ii) Countries with three or more surveys

Notes:

Sample sizes (respondents) for the 15 to 34 age group for each country and year are presented in Table GPS-8 part (ii).

Data taken from national surveys available in each country. Figures and methodology for each survey can be consulted in Table GPS-8 part (ii) in the Statistical bulletin 2011.

For young adults, the EMCDDA uses the range 15 to 34 years (Denmark and UK from 16 years, Germany, Estonia (1998) and Hungary from 18 years). In France, the age range was 25 to 34 in 1992 and 18 to 39 in 1995.

The most recent General population surveys reported by the Czech Republic display a wide variation in results, the reason for which is being explored, but may be due to differing sampling methods.  The data is provided for information, but given the lack of comparability between surveys should be treated with caution.

Related links:

Statistical bulletin 2008: Figure GPS-8 part (ii)

Statistical bulletin 2009: Figure GPS-8 part (ii)

Statistical bulletin 2010: Figure GPS-8 part (ii)

See also Table GPS-0

See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

Reitox national reports 2010, taken from population surveys, reports or scientific articles.

(see the help page for information about formats etc.)

Page last updated: Tuesday, 02 August 2011